Skip to content
7 stocks to buy that could make you a millionaire


Wall Street’s recent declines have baffled most investors. So far this year, the S&P500 the index lost about 21%. But you can still find some good stocks to buy right now.

Investing is a long-term strategy that helps many of us prepare for the years to come. Measurements suggest that between 1991 and 2020, the average return of the S&P 500 index has been well over 10%.

For example, suppose you are now 35 with $10,000 in savings and plan to retire at age 65. You decide to invest that $10,000 in several solid stocks and exchange-traded funds (ETFs). You will also make additional contributions of $4,800 per year at the end of each calendar year.

If the annual return is 8%, compounded once a year, at the end of those 35 years, the total amount saved will be almost $975,000. Concretely, saving $4,800 per year would be equivalent to setting aside $400 per month, or about $13 per day. And if annual returns increase to 9%, the total exceeds $1.2 million.

So, being a millionaire may very well be within your grasp. These stocks to buy give you a possible route to get there.

Teleprinter Company Current price
TXG 10x Genomics, Inc. $41.72
BRKR Bruker Corporation $61.20
ETSY Etsy, Inc. $74.09
PODD Island Corporation $207.93
TUE Marriott International, Inc. $136.46
HR HR $247.29
SEDG SolarEdge Technologies, Inc. $280.40

Stock to buy: 10X Genomics (TXG)

Credit: Michael Vi/Shutterstock

Biotechnology Group 10x Genomics (NASDAQ:TXG) designs genetic sequencing technology. It has more than 3,500 instruments used in various research institutions around the world. The biotechnology name focuses on five main areas: infectious diseases, immunology, cancer, neuroscience, and drug discovery.

In early May, 10x Genomics reported Q1 financial. Revenue totaled $114.5 million, representing an 8% year-over-year increase. Diluted net loss per share was 38 cents, compared to a loss of 11 cents a year earlier. Cash and cash equivalents were $539.3 million.

Recently, 10x Genomics spear two new products designed to increase the the adoption of its cellular analysis platform. The Fixed RNA Profiling Kit contains new tools designed to improve the speed and efficiency of RNA sequencing. Meanwhile, the Nuclei Isolation Kit enables the generation of nuclei suspensions from frozen samples for a fraction of the time and cost.

Despite the growth in operations, TXG stock dropped more than 7o% in 2022. Shares are trading at 10.56 times current sales. Meanwhilethe median 12-month forecast stands at $100.

Brucker (BRKR)

7 stocks to buy that could make you a millionaire

Source: Michael Vi / Shutterstock.com

Brucker (NASDAQ:BRKR) provides scientific instruments and equipment for various research and medical purposes. Its customers come from vast range of industries, such as life sciences, pharmaceuticals, agriculture and materials.

At the beginning of May, Bruker published Q1 results. Revenue was $595 million, representing a 7.3% increase from a year ago. Diluted EPS was 49 cents, compared to 44 cents a year earlier. Free cash flow (FCF) was $58.8 million.

Recently the company announcement key innovations focused on integrating mass spectrometry imaging into cell biology. Additionally, Bruker introduced a new state-of-the-art detector for X-ray spectrometers. The XFlash 7 will increase detection sensitivity and speed.

So far in 2022BRKR Stock declined 27%. The shares are trading at 3.7x trailing sales. Finally, the median forecast over 12 months stands at $78.

Etsy (ETSY)

7 stocks to buy that could make you a millionaire

Source: Sergey Yelagin / Shutterstock

E-commerce platform Etsy (NASDAQ:ETSY) makes our list of stocks to buy because it’ss have benefited from increased online sales during the pandemic. Management hopes the trend of online shopping will continue in the coming months.

ETSY reported Q1 May 4 results. Revenue was $579.3 million, up 5.2% from the first quarter of 2021. Diluted EPS generated 60 cents, and the e-commerce giant ended the quarter with 1 billion in cash and cash equivalents.

Recently, ETSY initiated a purchase buyer and seller protection program. The platform will invest at least $25 million for refunds on purchases, with no additional fees for sellers.

ETSY stock is down 66% in 2022 and 56% over a 12-month period. Shares change hands at 29.1x forward earnings and 5.1x sales. The 12-month price forecast for ETSY is $130.

Stock to buy: Insulet (PODD)

7 stocks to buy that could make you a millionaire

Source: Maria Wan / Shutterstock.com

Manufacturer of medical devices island (NASDAQ:PODD) is known for its flagship product, the Omnipod drug delivery system. It is a portable and programmable device that adheres to the patient’s body. This book the correct dosage at specified intervals.

In early May, Insulet reported Q1 financial results. Revenues totaled $295.4 million, an increase of 17.1% from a year ago. Diluted EPS was 40 cents, compared to a balanced quarter the previous year. Cash and cash equivalents totaled $709.6 million.

Recently the company innovated on a new manufacturing plant in Malaysia, which is expected to start production in 2024. In addition, Insulet present positive results of a study on its new Omnipod 5 insulin delivery system. This device is designed be used in the treatment of type 1 and type 2 diabetes.

PODD action lost about 22% so far this year. The shares are trading at 156.25x forward earnings and 12.10x trailing sales. The median 12-month forecast is $258.

Marriott International (MAR)

7 stocks to buy that could make you a millionaire

Source: DELBO ANDREA / Shutterstock

With approximately 8,000 properties, Marriott International (NASDAQ:TUE) is one of the largest hotel chains in the world. Its portfolio spans 30 brands, including Westin, Sheraton and Ritz-Carlton. Bonvoy, Marriott’s loyalty program, has more than 140 million members worldwide.

At the beginning of May, management announcement Q1 earnings. Total revenue reached $4.2 billion, an increase of 81% from a year ago. Diluted EPS was $1.14, compared to a diluted loss of 3 cents per share in Q1 2021. Cash and cash equivalents totaled $1 billion.

Since early June, Marriott has opened several new hotels around the world. Some of these new properties include the West Algarve in Portugal, Le Royal Meridien Doha in Qatar, and a Ritz-Carlton Hotel in Jordan.

Action MAR decreased by more than 17% in 2022. Forward P/E and P/S figures are 23.6x and 2.9x respectively. Median 12-month analyst forecast is at $180.50.

HR (HR)

7 stocks to buy that could make you a millionaire

Source: Andriy Blokhin / Shutterstock.com

Designer and retailer of home furnishings HR (NYSE:HR) has more than 70 venues in the United States and Canada, many of which are located in renovated historic buildings. Additionally, RH owns and operates restaurants and wine bars in select stores.

In other words, the group is on its way to becoming a luxury name. It is also known as one of Warren Buffett’s holdings. Berkshire Hathaway (NYSE:BRK.A) (New York stock market :BRK.B).

At the beginning of June, RH published Q1 results. Revenue rose 11% from a year ago to $957 million. Diluted net earnings per share were $12.16, compared to $4.19 the previous year. FCF was $107 million.

Recently the company announcement the opening of RH San Francisco in the historic Bethlehem Steel Building at Pier 70. The new store is a five-story gallery with a restaurant, wine bar and rooftop garden. Investors hope that the new site will contribute to the growth of the turnover of RH.

However, the HR stock has lost around half of its value so far in 2022. The forward P/E and P/S figures are 9.42x and 2.01x respectively. Finally, the median forecast over 12 months stands at $400.

Stock to buy: SolarEdge Technologies (SEDG)

7 stocks to buy that could make you a millionaire

Source: rafapress/Shutterstock.com

Specialist in alternative energy components SolarEdge Technologies (NASDAQ:SEDG) provides photovoltaic panels to increase energy production levels. This has developed the optimized DC inverter that reduces costs.

SEDG off Q1 May 2 results. Revenue reached a record $655.1 million, up 62% from a year ago. Diluted EPS was $1.20, down from 98 cents a year ago. The energy innovator generated strong cash flow of $163 million, up from $24.1 million a year ago.

Recently, the solar power plant spear a home energy management portfolio in Europe, expanding its market to the environmentally conscious continent. Additionally, SolarEdge open a 2 GWh battery cell plant in South Korea to meet growing demand for battery storage.

The SEDG stock is pretty much stable so far in the year. The shares are trading at 38.2x forward earnings and 7.1x sales. Analyst Price Predictions for SEDG is $359.

At the date of publication, Tezcan Gecgil did not hold (neither directly nor indirectly) any position in the securities mentioned in this article. The opinions expressed in this article are those of the author, subject to InvestorPlace.com publishing guidelines.

Tezcan Gecgil has worked in investment management for over two decades in the US and UK. In addition to formal higher education in the field, she has also completed all 3 levels of the Chartered Market Technician (CMT) exam. His passion is option trading based on the technical analysis of fundamentally sound companies. She particularly enjoys setting up covered weekly calls to generate income.

InvestorPlace

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.